Compound Monograph
Quercetagetin
Quercetagetin (6-hydroxyquercetin) is the signature yellow flavonol of marigold flowers — a preclinical antioxidant, Pim-1 kinase inhibitor and tyrosinase inhibitor, chemically prone to autoxidation.
Sources · 7
Where Does It Come From?
Quercetagetin is a naturally occurring flavonol, found in Marigold, French marigold, Mexican tarragon and 4 other sources. It is well tolerated orally (low toxicity).
Principal source Calendula Calendula officinalis Herb monograph →
Source Mexican Tarragon Tagetes lucida Herb monograph → Concentration
Content by Source
Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.
Quercetagetin at a Glance
Quercetagetin is a flavonol — specifically 6-hydroxyquercetin, i.e. quercetin carrying an extra hydroxyl group at the 6-position (systematic name 3,5,6,7,3’,4’-hexahydroxyflavone). It is the characteristic yellow flavonol pigment of marigold (Tagetes) flowers and is also reported in immature citrus peel 7,
Its pharmacology is entirely preclinical. The isolated molecule has two unusually specific enzyme activities for a plant flavonol — it is a moderately potent, ATP-competitive Pim-1 kinase inhibitor 3Reference 3Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinaseView study → and a tyrosinase inhibitor 4Reference 4Inhibition mechanism investigation of quercetagetin as a potential tyrosinase inhibitorView study → — alongside the anti-inflammatory and antioxidant behaviour typical of the flavonol class 5,
The honest headline is a chemical caveat: quercetagetin carries a B-ring catechol and an A-ring 5,6,7-trihydroxy (pyrogallol-type) motif, which makes it strongly reducing but also prone to autoxidation in neutral aqueous solution — a source of both its antioxidant readings and a stability/pro-oxidant liability 8,
Quercetagetin vs. Quercetin & Patuletin
The whole page turns on one added hydroxyl. Quercetagetin is quercetin plus a 6-OH group on the A-ring; its close relative patuletin is the 6-methyl ether of that same position (6-methoxyquercetin). So the three form a small, informative series:
- Quercetin — 3,5,7,3’,4’-pentahydroxyflavone (no 6-substituent); the abundant dietary parent.
- Quercetagetin — quercetin + 6-OH; the marigold pigment. The free 6-OH gives it an A-ring pyrogallol arrangement (5,6,7-trihydroxy), raising its metal-chelating and radical activity but also its autoxidation.
- Patuletin — the 6-O-methyl version; capping the 6-OH removes that pyrogallol reactivity.
That extra 6-oxygenation is not cosmetic. It is what lets quercetagetin fit the Pim-1 ATP pocket well enough to inhibit it selectively 3Reference 3Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinaseView study →, and its catechol/pyrogallol hydroxyls are what chelate the copper in tyrosinase 4Reference 4Inhibition mechanism investigation of quercetagetin as a potential tyrosinase inhibitorView study → — while also being the groups that oxidise. In several assays quercetagetin out-performs quercetin (e.g. it was the more potent anti-inflammatory of the two in keratinocytes 6Reference 6Anti-inflammatory effect of quercetagetin, an active component of immature Citrus unshiu, in HaCaT human keratinocytesView study →).
What It's Used For
Everything below is in-vitro or animal work on the isolated molecule or a marigold extract; none of it is human-validated.
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Every row here is preclinical (no human data), so the ceiling is low by design; read the per-row basis.
The most specific and best-characterised activity, and it is the isolated molecule that was tested. In a medicinal-chemistry study quercetagetin was identified as a moderately potent, ATP-competitive and reversible inhibitor of PIM1 kinase (IC50 ~0.34 uM), with >=7-fold selectivity over PIM2 and eight other serine/threonine kinases; a co-crystal structure (PDB 2O64) places it in the ATP pocket. In intact RWPE2 prostate-cancer cells it suppressed PIM1 activity dose-dependently (cellular ED50 ~5.5 uM) and inhibited growth in proportion to PIM1 expression 3Reference 3Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinaseView study →.
PIM1 is a recognised oncogene in leukaemia, lymphoma and prostate cancer.
Gap: this is a tool-compound / proof-of-concept result — cell and enzyme only, offered by its authors to validate PIM1 as a target, not as a therapeutic. No animal tumour or human data, and quercetagetin’s poor stability/bioavailability (see PK) undercuts translating a sub-micromolar enzyme IC50 into a systemic effect 3Reference 3Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinaseView study →.
The application with both mechanism and an animal model. In human HaCaT keratinocytes, quercetagetin (from immature Citrus unshiu) dose-dependently reduced IFN-gamma/TNF-alpha-induced TARC and MDC chemokines by lowering STAT1 phosphorylation, and was more effective than quercetin 6Reference 6Anti-inflammatory effect of quercetagetin, an active component of immature Citrus unshiu, in HaCaT human keratinocytesView study →.
In vivo, quercetagetin at 40 mg/kg/day significantly reduced joint destruction and preserved bone density in a mouse collagen-antibody-induced arthritis model, acting through Nrf2-dependent antioxidant induction and suppression of the Pten/AKT/NFATc1 axis to blunt osteoclast differentiation (with matching in-vitro osteoclast data at 2 uM) 5Reference 5Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axisView study →.
Gap: encouraging mechanistic + rodent evidence, but still animal/cell only; the arthritis dose is a mouse mg/kg figure with no human-equivalent or clinical follow-up, and the isolate was delivered directly, sidestepping quercetagetin’s oral-bioavailability problem 5,
Of interest for hyperpigmentation and cosmetic “skin-whitening” work. Against mushroom tyrosinase quercetagetin was a reversible, mixed-type inhibitor with IC50 ~0.19 mM — more potent than the kojic-acid standard in the same assay; it bound the enzyme-substrate complex preferentially (Kis ~0.12 mM), quenched tyrosinase fluorescence statically, altered its secondary structure (less alpha-helix), and chelated the enzyme’s catalytic copper at a 1:1 ratio 4Reference 4Inhibition mechanism investigation of quercetagetin as a potential tyrosinase inhibitorView study →.
Because tyrosinase is rate-limiting in melanin synthesis, this frames quercetagetin as a candidate depigmenting agent.
Gap: a single isolated-enzyme (mushroom, not human) study; no cellular melanocyte, skin-model or clinical confirmation, and — as with other flavonols — the catechol chemistry that inhibits tyrosinase is also the chemistry that oxidises, so formulation stability is unaddressed 4Reference 4Inhibition mechanism investigation of quercetagetin as a potential tyrosinase inhibitorView study →.
As a hexahydroxyflavone, quercetagetin is a strong in-vitro radical scavenger — DPPH IC50 ~27 uM and ABTS IC50 ~12 uM (comparable to quercetin), though notably weaker on hydroxyl radical — and it also showed in-vitro alpha-glucosidase, alpha-amylase and pancreatic-lipase inhibition as a marigold isolate 7Reference 7In vitroIn vitro antioxidant, anti-diabetic and antilipemic potentials of quercetagetin extracted from marigold (Tagetes erecta L.) inflorescence residuesView study →. Its B-ring catechol plus A-ring 5,6,7-trihydroxy motif make it an avid iron/copper chelator, the structural basis of much flavonol antioxidant capacity 10Reference 10Inhibition of mitochondrial respiration and cyanide-stimulated generation of reactive oxygen species by selected flavonoidsView study →.
Gap: whole-extract/isolate in-vitro chemistry with no human antioxidant outcome; worse, the same electron-rich hydroxyls mean quercetagetin autoxidises in neutral buffer, itself generating superoxide and H2O2 — so a “high antioxidant score” can partly reflect an unstable, potentially pro-oxidant molecule (see The Autoxidation Caveat) 8Reference 8Concise synthesis of quercetagetin (3,3’,4’,5,6,7-hexahydroxyflavone) with antioxidant and antibacterial activitiesView study →.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| PIM1 serine/threonine kinase | ATP-competitive, reversible inhibition (IC50 ~0.34 uM); >=7-fold selective vs PIM2/others; binds ATP pocket (PDB 2O64) | anticancer lead (prostate) |
| Tyrosinase (Cu-dependent) | reversible mixed-type inhibition (IC50 ~0.19 mM); 1:1 copper chelation + conformational change | skin depigmentation |
| STAT1 (IFN-gamma / TNF-alpha signalling) | dose-dependent decrease in STAT1 phosphorylation -> lower TARC/MDC chemokines | anti-inflammatory (skin) |
| Nrf2 / Keap1 and Pten/AKT/NFATc1 | activates Nrf2 antioxidant response; suppresses AKT-NFATc1 -> less osteoclast differentiation | anti-inflammatory / arthritisbone |
| Radical scavenging + Fe/Cu chelation | DPPH/ABTS scavenging; catechol + A-ring pyrogallol chelate metals | antioxidant (and the driver of autoxidation) |
| alpha-glucosidase / alpha-amylase / pancreatic lipase | non-competitive / mixed inhibition in vitro | metabolic (anti-diabetic/antilipemicpreclinical) |
The load-bearing point: the 6-OH-created A-ring pyrogallol is simultaneously what sharpens the metal-chelation/antioxidant chemistry and what makes the molecule autoxidise — potency and instability come from the same feature.
Pharmacokinetics
Quercetagetin’s human pharmacokinetics are not characterised. By close analogy to quercetin — and as flagged in the compound’s systematic review — an ingested flavonol aglycone of this type is expected to have low oral bioavailability, extensive phase-II (glucuronide/sulfate) conjugation and rapid clearance, which is precisely why delivery systems (encapsulation, nanoformulation) are being explored for it 9Reference 9Systematic reviewA systematic review on the research status of quercetagetin: resources, biosynthesis, bioavailability, bioactive-delivery systems, health effects, marketed functional products and patentsView study →. Compounding this, the free 6-OH/catechol makes quercetagetin chemically unstable in neutral aqueous conditions, autoxidising to quinones with superoxide/H2O2 release 8Reference 8Concise synthesis of quercetagetin (3,3’,4’,5,6,7-hexahydroxyflavone) with antioxidant and antibacterial activitiesView study →. Both facts mean the sub-micromolar Pim-1 and sub-millimolar tyrosinase potencies seen in vitro should not be assumed to translate to systemic exposure in vivo.
Clinical Trials
There are no clinical trials of quercetagetin. The entire evidence base is enzyme assays, cell work and a single rodent arthritis model.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| — | — | — | Pim-1 kinase, tyrosinase, anti-inflammatory (STAT1 / Nrf2 / osteoclast), antioxidant & metabolic-enzyme assays |
Last checked: July 2026.
The Autoxidation Caveat
Quercetagetin is a useful cautionary example of why a high antioxidant reading is not automatically a good thing. Redox-active flavonols with catechol and pyrogallol hydroxylation — a group that includes quercetagetin, quercetin and myricetin — autoxidise in neutral aqueous buffer, consuming oxygen and producing superoxide (O2-) and hydrogen peroxide (H2O2) along with semiquinone and quinone species 8,
Practically this means: (1) some “antioxidant” assay signal is the molecule oxidising itself rather than protecting a target; (2) under the wrong conditions (neutral pH, transition-metal traces) the same chemistry can turn pro-oxidant; and (3) formulations must protect it. It does not make quercetagetin dangerous at dietary levels, but it is the reason its bench potency and its real-world usefulness can diverge.
Its Role in Plants
Quercetagetin is a flower pigment. It accumulates as the free flavonol and as glycosides (e.g. quercetagetin-7-O-glucoside) in the ray florets and petals of Tagetes, contributing to their deep yellow-orange colouration and to UV-protective / antioxidant defence 1,
These are plant-pigment and plant-defence functions and should not be read as human pharmacology.
Prevalence in Nature
Quercetagetin is best known as the signature flavonol of the genus Tagetes (marigolds), occurring in Tagetes erecta (African/Aztec marigold), T. patula (French marigold), T. lucida (Mexican tarragon / yerbaniz) and T. minuta 1,
Discovery & Synthesis
Quercetagetin (CAS 90-18-6) has long been recognised as the characteristic flavonol pigment of marigold flowers, from which it is conventionally obtained by extraction — historically as a co-product of Tagetes processing for xanthophyll/lutein pigments. Because it is a fully hydroxylated flavonol it is not usually made industrially by synthesis; the isolation-from-marigold route dominates 7,
A concise laboratory total synthesis was reported by Bulut and Yilmaz in 2021 (Results in Chemistry), assembling 3,5,6,7,3’,4’-hexahydroxyflavone and confirming antioxidant and antibacterial activity of the synthetic material — useful for supplying defined, high-purity quercetagetin for research where the plant-extracted molecule’s variability and autoxidation are problematic 8Reference 8Concise synthesis of quercetagetin (3,3’,4’,5,6,7-hexahydroxyflavone) with antioxidant and antibacterial activitiesView study →. A 2025 systematic review catalogues its resources, biosynthesis, bioavailability and emerging delivery systems 9Reference 9Systematic reviewA systematic review on the research status of quercetagetin: resources, biosynthesis, bioavailability, bioactive-delivery systems, health effects, marketed functional products and patentsView study →.
Patents: not yet researched.
Toxicity & Safety
Quercetagetin carries a low toxicity flag: it is a minor dietary flavonol of edible marigold and citrus material, consumed by people for centuries at low levels with no signal of harm, and no acute toxicity has been reported for the amounts encountered in food. As with the whole flavonol class, a dedicated human safety, genotoxicity or reproductive-toxicity dataset has not been characterised for the isolated molecule, so absence of evidence is not evidence of safety at supplement-scale doses.
- Low-concern dietary flavonol. Present in edible marigold and citrus-peel material at low levels with no reported acute toxicity.
- Chemically unstable / potentially pro-oxidant. Autoxidises in neutral aqueous solution, generating superoxide and H2O2; under metal-rich conditions its antioxidant chemistry can flip pro-oxidant.
- No human safety data. No clinical, genotoxicity or reproductive-toxicity characterisation of the isolate; interactions and high-dose effects are unstudied.
- Metal chelation is double-edged. Its avid iron/copper chelation underlies both its antioxidant readings and its enzyme inhibition, and could in principle affect metal handling at high intake — untested in humans.
Dosage
There is no established human dose for quercetagetin. It has been studied only in the laboratory: as an isolated molecule in enzyme and cell assays (Pim-1 kinase IC50 ~0.34 uM 3Reference 3Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinaseView study →; tyrosinase IC50 ~0.19 mM 4Reference 4Inhibition mechanism investigation of quercetagetin as a potential tyrosinase inhibitorView study →; DPPH/ABTS antioxidant IC50 in the low-micromolar range 7Reference 7In vitroIn vitro antioxidant, anti-diabetic and antilipemic potentials of quercetagetin extracted from marigold (Tagetes erecta L.) inflorescence residuesView study →) and at 40 mg/kg/day in a mouse arthritis model 5Reference 5Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axisView study →. Human dietary exposure is indirect, from marigold-flower and citrus-peel material, at uncharacterised levels. These are research figures, not a personal recommendation.
References
- Kim JH, Duan S, Lim YJ, Eom SH (2022). Changes in quercetin derivatives and antioxidant activity in marigold petals (Tagetes patula L.) induced by ultraviolet-B irradiation and methyl jasmonate. Plants (Basel). https://pubmed.ncbi.nlm.nih.gov/36365399/
- Aquino R, Cáceres A, Morelli S, Rastrelli L (2002). An extract of Tagetes lucida and its phenolic constituents as antioxidants. Journal of Natural Products. https://pubmed.ncbi.nlm.nih.gov/12502312/
- Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, Neidigh JW, Lilly MB (2007). Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Molecular Cancer Therapeutics. https://pubmed.ncbi.nlm.nih.gov/17218638/
- Liang F (2024). Inhibition mechanism investigation of quercetagetin as a potential tyrosinase inhibitor. Frontiers in Chemistry. https://pubmed.ncbi.nlm.nih.gov/38894729/
- Wang H, Yuan T, Wang J, Li D, Lee WY, Li Z, Sun S (2025). Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axis. Arthritis Research & Therapy. https://pubmed.ncbi.nlm.nih.gov/40057805/
- Kang GJ, Han SC, Ock JW, Kang HK, Yoo ES (2013). Anti-inflammatory effect of quercetagetin, an active component of immature Citrus unshiu, in HaCaT human keratinocytes. Biomolecules & Therapeutics (Seoul). https://pubmed.ncbi.nlm.nih.gov/24009872/
- Wang W, Xu H, Chen H, Tai K, Liu F, Gao Y (2016). In vitro antioxidant, anti-diabetic and antilipemic potentials of quercetagetin extracted from marigold (Tagetes erecta L.) inflorescence residues. Journal of Food Science and Technology. https://pubmed.ncbi.nlm.nih.gov/27478217/
- Bulut O, Yilmaz MD (2021). Concise synthesis of quercetagetin (3,3’,4’,5,6,7-hexahydroxyflavone) with antioxidant and antibacterial activities. Results in Chemistry. https://doi.org/10.1016/j.rechem.2021.100255
- Zhang H, Farag MA, Cao H, et al. (2025). A systematic review on the research status of quercetagetin: resources, biosynthesis, bioavailability, bioactive-delivery systems, health effects, marketed functional products and patents. Phytochemistry Reviews. https://doi.org/10.1007/s11101-025-10078-w
- Hodnick WF, Duval DL, Pardini RS (1994). Inhibition of mitochondrial respiration and cyanide-stimulated generation of reactive oxygen species by selected flavonoids. Biochemical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/8117326/
